AN2 Therapeutics, Inc News, AN2 Therapeutics, Inc Quote, ANTX Quote

AN2 Therapeutics, Inc (NQ:ANTX) Delayed: 3.63 +0.08 (2.25%)

Prev. Close

$3.55

Today 6M 1Y 5Y

Open

$3.55

52 Wk High

$48.59

52 Wk Low

$40.72

Day High

$3.70

Day Low

$3.50

P/E

N/A

EPS

$-0.01

Volume

195,975

ALERTS | RSS

Oct 23, 2026 05:00 PM AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)
Oct 21, 2026 07:00 AM AN2 Therapeutics to present Phase 2 epetraborole trial design at MPN congress
Oct 21, 2026 07:00 AM AN2 Therapeutics to Present Phase 2 Design for Epetraborole in Polycythemia Vera at the 18th International Congress on Myeloproliferative Neoplasms
Oct 20, 2026 04:13 PM AN2 Therapeutics to Participate at Upcoming Investor Conferences
Oct 13, 2026 05:13 PM Form 4 AN2 Therapeutics, Inc. For: Oct 12 Filed by: Marks Gilbert Lynn
Oct 13, 2026 05:13 PM Form 4 AN2 Therapeutics, Inc. For: Oct 12 Filed by: Martin Patricia A.
Oct 13, 2026 05:12 PM Form 4 AN2 Therapeutics, Inc. For: Oct 12 Filed by: Aziz Kabeer
Sep 28, 2026 07:02 AM Gates Foundation extends funding for AN2 and GSK tuberculosis research
Sep 28, 2026 07:00 AM AN2 Therapeutics Announces Extension of Funding for Tuberculosis Research Collaboration with GSK
Sep 16, 2026 05:35 PM Form 4 AN2 Therapeutics, Inc. For: Sep 15 Filed by: Trenor Cameron C. III

Entities mentioned with ANTX

View All Entities